• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过在昆虫细胞中共表达人多药耐药蛋白的两个半分子来重建ATP依赖性白三烯C4转运。

Reconstitution of ATP-dependent leukotriene C4 transport by Co-expression of both half-molecules of human multidrug resistance protein in insect cells.

作者信息

Gao M, Loe D W, Grant C E, Cole S P, Deeley R G

机构信息

Cancer Research Laboratories, Queen's University, Kingston, Ontario K7L 3N6, Canada.

出版信息

J Biol Chem. 1996 Nov 1;271(44):27782-7. doi: 10.1074/jbc.271.44.27782.

DOI:10.1074/jbc.271.44.27782
PMID:8910374
Abstract

Multidrug resistance protein (MRP) confers a multidrug resistance phenotype similar to that associated with overexpression of P-glycoprotein. Unlike P-glycoprotein, MRP has also been shown to be a primary active ATP-dependent transporter of conjugated organic anions. The mechanism(s) by which MRP transports these compounds and increases resistance to natural product drugs is unknown. To facilitate studies on the structure and function of MRP, we have determined whether a baculovirus expression system can be used to produce active protein. Full-length MRP as well as molecules corresponding to either the NH2- or COOH-proximal halves of the protein were expressed individually and in combination in Spodoptera frugiperda Sf21 cells. High levels of intact and half-length proteins were detected in membrane vesicles from infected cells. Although underglycosylated, the full-length protein transported leukotriene C4 (LTC4) with kinetic parameters very similar to those of MRP produced in transfected HeLa cells. Neither half-molecule was able to transport LTC4. However, a functional transporter with characteristics similar to those of intact protein could be reconstituted when both half-molecules were co-expressed. Transport of LTC4 by Sf21 membrane vesicles containing either intact or reconstituted MRP was competitively inhibited by both S-decylglutathione and 17beta-estradiol 17-(beta-D-glucuronide), with Ki values similar to those reported previously for MRP expressed in HeLa cells (Loe, D. W., Almquist, K. C., Deeley, R. G., and Cole, S. P. C. (1996) J. Biol. Chem. 271, 9675-9682; Loe, D. W., Almquist, K. C., Cole, S. P. C., and Deeley, R. G. (1996) J. Biol. Chem. 271, 9683-9689). These studies demonstrate that human MRP produced in insect cells can function as an active transporter of LTC4 and that the NH2- and COOH-proximal halves of the protein can assemble efficiently to form a transporter with functional characteristics similar to those of the intact protein.

摘要

多药耐药蛋白(MRP)赋予的多药耐药表型与P-糖蛋白过表达相关的表型相似。与P-糖蛋白不同,MRP还被证明是一种依赖ATP的共轭有机阴离子的原发性主动转运蛋白。MRP转运这些化合物并增加对天然产物药物耐药性的机制尚不清楚。为了便于对MRP的结构和功能进行研究,我们确定了杆状病毒表达系统是否可用于产生活性蛋白。全长MRP以及与该蛋白的NH2端或COOH端近端一半相对应的分子分别或组合在草地贪夜蛾Sf21细胞中表达。在感染细胞的膜泡中检测到高水平的完整和半长蛋白。尽管糖基化不足,但全长蛋白转运白三烯C4(LTC4)的动力学参数与转染的HeLa细胞中产生的MRP非常相似。两个半分子均不能转运LTC4。然而,当两个半分子共表达时,可以重建一个具有与完整蛋白相似特征的功能性转运蛋白。含有完整或重组MRP的Sf21膜泡对LTC4的转运受到S-癸基谷胱甘肽和17β-雌二醇17-(β-D-葡萄糖醛酸)的竞争性抑制,其Ki值与先前报道的HeLa细胞中表达的MRP相似(Loe,D.W.,Almquist,K.C.,Deeley,R.G.和Cole,S.P.C.(1996)J.Biol.Chem.271,9675-9682;Loe,D.W.,Almquist,K.C.,Cole,S.P.C.和Deeley,R.G.(1996)J.Biol.Chem.271,9683-9689)。这些研究表明,在昆虫细胞中产生的人MRP可以作为LTC4的活性转运蛋白发挥作用,并且该蛋白的NH2端和COOH端近端一半可以有效组装形成具有与完整蛋白相似功能特征的转运蛋白。

相似文献

1
Reconstitution of ATP-dependent leukotriene C4 transport by Co-expression of both half-molecules of human multidrug resistance protein in insect cells.通过在昆虫细胞中共表达人多药耐药蛋白的两个半分子来重建ATP依赖性白三烯C4转运。
J Biol Chem. 1996 Nov 1;271(44):27782-7. doi: 10.1074/jbc.271.44.27782.
2
ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids.多药耐药蛋白(MRP)介导的ATP依赖性17β-雌二醇17-(β-D-葡萄糖醛酸苷)转运。胆汁淤积性类固醇的抑制作用。
J Biol Chem. 1996 Apr 19;271(16):9683-9. doi: 10.1074/jbc.271.16.9683.
3
Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport.多药耐药蛋白(MRP)介导的白三烯C4和化疗药物在膜囊泡中的转运。谷胱甘肽依赖性长春新碱转运的证明。
J Biol Chem. 1996 Apr 19;271(16):9675-82. doi: 10.1074/jbc.271.16.9675.
4
Multidrug resistance protein. Identification of regions required for active transport of leukotriene C4.
J Biol Chem. 1998 Apr 24;273(17):10733-40. doi: 10.1074/jbc.273.17.10733.
5
ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter.膜囊泡对天然产物细胞毒性药物的ATP依赖性摄取确立了多药耐药相关蛋白作为一种广谱特异性转运蛋白的地位。
Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6929-34. doi: 10.1073/pnas.93.14.6929.
6
The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates.MRP基因编码一种针对白三烯C4及结构相关共轭物的ATP依赖性外排泵。
J Biol Chem. 1994 Nov 11;269(45):27807-10.
7
ATP-dependent glutathione disulphide transport mediated by the MRP gene-encoded conjugate export pump.由MRP基因编码的共轭物输出泵介导的ATP依赖性谷胱甘肽二硫化物转运
Biochem J. 1996 Mar 1;314 ( Pt 2)(Pt 2):433-7. doi: 10.1042/bj3140433.
8
Characterization of the ATP-dependent LTC4 transporter in cisplatin-resistant human KB cells.顺铂耐药的人KB细胞中ATP依赖型白三烯C4转运体的特性研究
Biochem Biophys Res Commun. 1996 Sep 4;226(1):158-65. doi: 10.1006/bbrc.1996.1326.
9
Functional expression of multidrug resistance protein 1 in Pichia pastoris.多药耐药蛋白1在毕赤酵母中的功能性表达。
Biochemistry. 2001 Jul 27;40(28):8307-16. doi: 10.1021/bi010093c.
10
Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione.分子量为190,000的多药耐药蛋白(MRP)介导长春新碱转运的特性:与谷胱甘肽协同转运的证据
Cancer Res. 1998 Nov 15;58(22):5130-6.

引用本文的文献

1
Functional role of oligomerization for bacterial and plant SWEET sugar transporter family.细菌和植物 SWEET 糖转运蛋白家族寡聚化的功能作用。
Proc Natl Acad Sci U S A. 2013 Sep 24;110(39):E3685-94. doi: 10.1073/pnas.1311244110. Epub 2013 Sep 11.
2
Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks.杆状病毒表达载体在昆虫细胞培养中的共表达与共感染:优缺点。
Biotechnol Adv. 2012 May-Jun;30(3):766-81. doi: 10.1016/j.biotechadv.2012.01.009. Epub 2012 Jan 28.
3
Oligomerization of human ATP-binding cassette transporters and its potential significance in human disease.
人类ATP结合盒转运蛋白的寡聚化及其在人类疾病中的潜在意义。
Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1049-63. doi: 10.1517/17425250903124371.
4
Membrane topology of the human multidrug resistance-associated protein (MRP) and its homologs.人类多药耐药相关蛋白(MRP)及其同源物的膜拓扑结构。
Cytotechnology. 1998 Sep;27(1-3):71-9. doi: 10.1023/A:1008031914247.
5
Role of the Caenorhabditis elegans multidrug resistance gene, mrp-4, in gut granule differentiation.秀丽隐杆线虫多药耐药基因mrp-4在肠道颗粒分化中的作用。
Genetics. 2007 Nov;177(3):1569-82. doi: 10.1534/genetics.107.080689. Epub 2007 Oct 18.
6
Role of the NH2-terminal membrane spanning domain of multidrug resistance protein 1/ABCC1 in protein processing and trafficking.多药耐药蛋白1/ABCC1的氨基末端跨膜结构域在蛋白质加工和转运中的作用。
Mol Biol Cell. 2005 May;16(5):2483-92. doi: 10.1091/mbc.e04-12-1113. Epub 2005 Mar 16.
7
Severed channels probe regulation of gating of cystic fibrosis transmembrane conductance regulator by its cytoplasmic domains.切割通道探究囊性纤维化跨膜电导调节因子门控受其胞质结构域的调控。
J Gen Physiol. 2000 Sep;116(3):477-500. doi: 10.1085/jgp.116.3.477.
8
Multidrug resistance protein MRP1 protects against the toxicity of the major lipid peroxidation product 4-hydroxynonenal.多药耐药蛋白MRP1可抵御主要脂质过氧化产物4-羟基壬烯醛的毒性。
Biochem J. 2000 Sep 1;350 Pt 2(Pt 2):555-61.
9
Severed molecules functionally define the boundaries of the cystic fibrosis transmembrane conductance regulator's NH(2)-terminal nucleotide binding domain.切割后的分子在功能上界定了囊性纤维化跨膜传导调节因子氨基末端核苷酸结合域的边界。
J Gen Physiol. 2000 Aug;116(2):163-80. doi: 10.1085/jgp.116.2.163.
10
Epitope mapping of monoclonal antibodies specific for the 190-kDa multidrug resistance protein (MRP).针对190 kDa多药耐药蛋白(MRP)的单克隆抗体的表位作图
Br J Cancer. 1998 Nov;78(9):1134-40. doi: 10.1038/bjc.1998.642.